Differential toxicity of DNA adducts of mitomycin C

Journal of Nucleic Acids

Volumn 2010, Issue , 2010, Pages

  Bargonetti, Jill ^a   Champeil, Elise ^b   Tomasz, Maria ^a  

^a CITY UNIVERSITY OF NEW YORK   (United States)

^b JOHN JAY COLLEGE OF CRIMINAL JUSTICE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CHECKPOINT KINASE 1; DNA; MITOMYCIN C; PROTEIN P53;

CANCER CELL; CELL DEATH; CHIRALITY; DNA ADDUCT; DNA CROSS LINKING; DNA SEQUENCE; DRUG STRUCTURE; NONHUMAN; PRIORITY JOURNAL; REVIEW; STREPTOMYCES;

MAMMALIA;

EID: 84865355889     PISSN: 20900201     EISSN: 2090021X     Source Type: Journal    
DOI: 10.4061/2010/698960     Document Type: Review

References (34)

1. Hata T., Hoshi T., Kanamori K., Mitomycin, a new antibiotic from Streptomyces. I. The Journal of Antibiotics 1956 9 141 146
2. Carter S. K., Crooke S. T. E., Mitomycin C: Current Status and New Developments 1979 New York, NY, USA Academic Press
3. Iyer V. N., Szybalski W., A molecular mechanism of mitomycin action: linking of complementary DNA strands. Proceedings of the National Academy of Sciences of the United States of America 1963 50 355 362
4. Armstrong R. W., Salvati M. E., Nguyen M., Novel interstrand cross-links induced by the antitumor antibiotic carzinophilin/azinomycin B. Journal of the American Chemical Society 1992 114 8 3144 3145 2-s2.0-0026756615
5. Tomasz M., Lipman R., Chowdary D., Isolation and structure of a covalent cross-link adduct between mitomycin C and DNA. Science 1987 235 4793 1204 1208 2-s2.0-0023123806 (Pubitemid 17034007)
6. Tomasz M., Mitomycin C: small, fast and deadly (but very selective). Chemistry and Biology 1995 2 9 575 579 2-s2.0-0029360580
7. Tomasz M., Lipman R., Reductive metabolism and alkylating activity of mitomycin C induced by rat liver microsomes. Biochemistry 1981 20 17 5056 5061 2-s2.0-0019835111 (Pubitemid 12195997)
8. Cummings J., Spanswick V. J., Smyth J. F., Re-evaluation of the molecular pharmacology of Mitomycin C. European Journal of Cancer Part A 1995 31 12 1928 1933 2-s2.0-0029566296 10.1016/0959-8049(95)00364-9 (Pubitemid 26023082)
9. Palom Y., Belcourt M. F., Kumar G. S., Arai H., Kasai M., Sartorelli A. C., Rockwell S., Tomasz M., Formation of a major DNA adduct of the mitomycin metabolite 2,7-diaminomitosene in EMT6 mouse mammary tumor cells treated with mitomycin C. Oncology Research 1998 10 10 509 521 2-s2.0-0032242916 (Pubitemid 128736340)
10. Palom Y., Belcourt M. F., Musser S. M., Sartorelli A. C., Rockwell S., Tomasz M., Structure of adduct X, the last unknown of the six major DNA adducts of mitomycin C formed in EMT6 mouse mammary tumor cells. Chemical Research in Toxicology 2000 13 6 479 488 2-s2.0-0000797824 10.1021/tx000024j (Pubitemid 30416343)
11. Kumar G. S., Musser S. M., Cummings J., Tomasz M., 2,7-Diaminomitosene, a monofunctional mitomycin C derivative, alkylates DNA in the major groove. Structure and base-sequence specificity of the DNA adduct and mechanism of the alkylation. Journal of the American Chemical Society 1996 118 39 9209 9217 2-s2.0-0001229584 10.1021/ja9607401 (Pubitemid 26355113)
12. Palom Y., Belcourt M. F., Tang L.-Q., Mehta S. S., Sartorelli A. C., Pritsos C. A., Pritsos K. L., Rockwell S., Tomasz M., Bioreductive metabolism of mitomycin C in EMT6 mouse mammary tumor cells: cytotoxic and non-cytotoxic pathways, leading to different types of DNA adducts. The effect of dicumarol. Biochemical Pharmacology 2001 61 12 1517 1529 2-s2.0-0035877170 10.1016/S0006-2952(01)00609-8 (Pubitemid 32476906)
13. Abbas T., Olivier M., Lopez J., Houser S., Xiao G., Kumar G. S., Tomasz M., Bargonetti J., Differential activation of p53 by the various adducts of mitomycin C. Journal of Biological Chemistry 2002 277 43 40513 40519 2-s2.0-0037175052 10.1074/jbc.M205495200 (Pubitemid 35215629)
14. Utzat C. D., Clement C. C., Ramos L. A., Das A., Tomasz M., Basu A. K., DNA adduct of the mitomycin C metabolite 2,7-diaminomitosene is a nontoxic and nonmutagenic DNA lesion in vitro and in vivo. Chemical Research in Toxicology 2005 18 2 213 223 2-s2.0-13844269362 10.1021/tx049813h (Pubitemid 40256239)
15. Kinoshita S., Uzu K., Nakano K., Takahashi T., Mitomycin derivatives. 2. Derivatives of decarbamoylmitosane and decarbamoylmitosene. Journal of Medicinal Chemistry 1971 14 2 109 112 2-s2.0-0015012750
16. Carrano A. V., Thompson L. H., Stetka D. G., DNA crosslinking, sister-chromatid exchange and specific mutations. Mutation Research 1979 63 1 175 188 2-s2.0-0018640307 (Pubitemid 10199112)
17. Tomasz M., Lipman R., McGuinness B. F., Nakanishi K., Isolation and characterization of a major adduct between mitomycin C and DNA. Journal of the American Chemical Society 1988 110 17 5892 5896 2-s2.0-0023772270
18. Hoban P. R., Walton M. I., Robson C. N., Godden J., Stratford I. J., Workman P., Harris A. L., Hickson I. D., Decreased NADPH: cytochrome P-450 reductase activity and impaired drug activation in a mammalian cell line resistant to mitomycin C under aerobic but not hypoxic conditions. Cancer Research 1990 50 15 4692 4697 2-s2.0-0025352024 (Pubitemid 20230414)
19. Rockwell S., Kim S. Y., Cytotoxic potential of monoalkylation products between mitomycins and DNA: studies of decarbamoyl mitomycin C in wild-type and repair-deficient cell lines. Oncology Research 1995 7 1 39 47 2-s2.0-0029086720
20. Palom Y., Kumar G. S., Tang L.-Q., Paz M. M., Musser S. M., Rockwell S., Tomasz M., Relative toxicities of DNA cross-links and monoadducts: new insights from studies of decarbamoyl mitomycin C and mitomycin C. Chemical Research in Toxicology 2002 15 11 1398 1406 2-s2.0-0036852787 10.1021/tx020044g (Pubitemid 35364901)
21. Ramos L. A., Lipman R., Tomasz M., Basu A. K., The major mitomycin C-DNA monoadduct is cytotoxic but not mutagenic in Escherichia coli. Chemical Research in Toxicology 1998 11 1 64 69 2-s2.0-0031884662 10.1021/tx970163+ (Pubitemid 28065274)
22. Basu A. K., Hanrahan C. J., Malia S. A., Kumar S., Bizanek R., Tomasz M., Effect of site-specifically located mitomycin C-DNA monoadducts on in vitro DNA synthesis by DNA polymerases. Biochemistry 1993 32 18 4708 4718 2-s2.0-0027271948 10.1021/bi00069a004 (Pubitemid 23162025)
23. Paz M. M., Ladwa S., Champeil E., Liu Y., Rockwell S., Boamah E. K., Bargonetti J., Callahan J., Roach J., Tomasz M., Mapping DNA adducts of mitomycin C and decarbamoyl mitomycin C in cell lines using liquid chromatography/electrospray tandem mass spectrometry. Chemical Research in Toxicology 2008 21 12 2370 2378 2-s2.0-58149092958 10.1021/tx8002615
24. Boamah E. K., White D. E., Talbott K. E., Arva N. C., Berman D., Tomasz M., Bargonetti J., Mitomycin-DNA adducts induce p53-dependent and p5-independent cell death pathways. ACS Chemical Biology 2007 2 6 399 407 2-s2.0-34547586075 10.1021/cb700060t (Pubitemid 350010544)
25. Halazonetis T. D., Gorgoulis V. G., Bartek J., An oncogene-induced DNA damage model for cancer development. Science 2008 319 5868 1352 1355 2-s2.0-40449120350 10.1126/science.1140735 (Pubitemid 351354863)
26. Vousden K. H., Prives C., Blinded by the light: the growing complexity of p53. Cell 2009 137 3 413 431 2-s2.0-65349103899 10.1016/j.cell.2009.04.037
27. Zhou B. B., Anderson H. J., Roberge M., Targeting DNA checkpoint kinases in cancer therapy. Cancer Biology & Therapy 2003 2 4 S16 S22 2-s2.0-1542751745
28. Ben-Yehoyada M., Wang L. C., Kozekov I. D., Rizzo C. J., Gottesman M. E., Gautier J., Checkpoint signaling from a single DNA interstrand crosslink. Molecular Cell 2009 35 5 704 715 2-s2.0-69749095427 10.1016/j.molcel.2009.08.014
29. Reinhardt H. C., Aslanian A. S., Lees J. A., Yaffe M. B., p53-deficient cells rely on ATM- and ATR-mediated checkpoint signaling through the p38MAPK/MK2 pathway for survival after DNA damage. Cancer Cell 2007 11 2 175 189 2-s2.0-33846821915 10.1016/j.ccr.2006.11.024 (Pubitemid 46209849)
30. Liu Q., Guntuku S., Cui X.-S., Matsuoka S., Cortez D., Tamai K., Luo G., Carattini-Rivera S., DeMayo F., Bradley A., Donehower L. A., Elledge S. J., Chk1 is an essential kinase that is regulated by Atr and required for the G2/M DNA damage checkpoint. Genes and Development 2000 14 12 1448 1459 2-s2.0-17644432403 (Pubitemid 30421838)
31. Zhang Y.-W., Otterness D. M., Chiang G. G., Xie W., Liu Y.-C., Mercurio F., Abraham R. T., Genotoxic stress targets human Chk1 for degradation by the ubiquitin-proteasome pathway. Molecular Cell 2005 19 5 607 618 2-s2.0-24044476837 10.1016/j.molcel.2005.07.019 (Pubitemid 41219437)
32. Sidi S., Sanda T., Kennedy R. D., Hagen A. T., Jette C. A., Hoffmans R., Pascual J., Imamura S., Kishi S., Amatruda J. F., Kanki J. P., Green D. R., D'Andrea A. A., Look A. T., Chk1 suppresses a caspase-2 apoptotic response to DNA damage that bypasses p53, Bcl-2, and caspase-3. Cell 2008 133 5 864 877 2-s2.0-44149090307 10.1016/j.cell.2008.03.037 (Pubitemid 351715394)
33. Boamah E. K., Brekman A., Tomasz M., DNA adducts of decarbamoyl mitomycin C efficiently kill cells with compromised p53 resulting from proteasome-mediated degradation of Chk1. Chemical Research in Toxicology 2010 23 7 1151 1162
34. Shen X., Do H., Li Y., Chung W.-H., Tomasz M., de Winter J. P., Xia B., Elledge S. J., Wang W., Li L., Recruitment of fanconi anemia and breast cancer proteins to DNA damage sites is differentially governed by replication. Molecular Cell 2009 35 5 716 723 2-s2.0-69749106825 10.1016/j.molcel.2009.06.034